1941 related articles for article (PubMed ID: 32586585)
1. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
2. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
[TBL] [Abstract][Full Text] [Related]
3. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
[TBL] [Abstract][Full Text] [Related]
4. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
Black-Maier E; Piccini JP; Granger CB
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
[TBL] [Abstract][Full Text] [Related]
5. Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trial.
Branny M; Osmancik P; Kala P; Poloczek M; Herman D; Neuzil P; Hala P; Taborsky M; Stasek J; Haman L; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Hozman M; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Cardiovasc Electrophysiol; 2023 Sep; 34(9):1885-1895. PubMed ID: 37529864
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.
Kar S; Doshi SK; Alkhouli M; Camm AJ; Coylewright M; Gibson MC; Granger CB; Gurol ME; Huber K; Mansour M; Nair DG; Natale A; Pocock SJ; Reddy VR; Saliba W; Christen T; Allocco DJ; Ellenbogen KA; Leon MB
Am Heart J; 2023 Oct; 264():123-132. PubMed ID: 37279840
[TBL] [Abstract][Full Text] [Related]
7. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation.
Jiang H; Koh TH; Vengkat V; Fei G; Ding ZP; Ewe SH; Jappar I; Lim ST; Yap J
Am J Cardiol; 2023 Aug; 200():135-143. PubMed ID: 37321026
[TBL] [Abstract][Full Text] [Related]
8. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
[TBL] [Abstract][Full Text] [Related]
11. Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis.
Fassini G; Gasperetti A; Italiano G; Riva S; Moltrasio M; Dello Russo A; Casella M; Maltagliati A; Tundo F; Majocchi B; Arioli L; Al-Mohani G; Pontone G; Pepi M; Tondo C
Heart Rhythm; 2019 Sep; 16(9):1320-1326. PubMed ID: 30928784
[TBL] [Abstract][Full Text] [Related]
12. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
[TBL] [Abstract][Full Text] [Related]
14. Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL Studies.
Brouwer TF; Whang W; Kuroki K; Halperin JL; Reddy VY
J Am Heart Assoc; 2019 Dec; 8(23):e013525. PubMed ID: 31752643
[TBL] [Abstract][Full Text] [Related]
15. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
Takeda K; Tsuboko Y; Iwasaki K
Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
[TBL] [Abstract][Full Text] [Related]
16. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
Reddy VY; Akehurst RL; Amorosi SL; Gavaghan MB; Hertz DS; Holmes DR
Stroke; 2018 Jun; 49(6):1464-1470. PubMed ID: 29739915
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial.
Ye C; Han X; Chen Y; Liu F; Ma H; Yang Y; Liu Y; Hu Q; Yao Q; Xie W; Xu D
BMJ Open; 2022 Oct; 12(10):e063931. PubMed ID: 36307161
[TBL] [Abstract][Full Text] [Related]
19. Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage.
Hutt E; Wazni OM; Saliba WI; Kanj M; Tarakji KG; Aguilera J; Barakat AF; Rasmussen P; Uchino K; Russman A; Hussain S; Wisco D; Kapadia S; Lindsay BD; Hussein AA
Heart Rhythm; 2019 May; 16(5):663-668. PubMed ID: 30521942
[TBL] [Abstract][Full Text] [Related]
20. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
